Method for regulating and controlling form of saccharomyces cerevisiae to increase content of yeast protein
By overexpressing the cytoskeleton and cell cycle-related genes in Saccharomyces cerevisiae, the morphology of Saccharomyces cerevisiae is solved, and the efficient synthesis and production efficiency of yeast protein is improved.
Patent Information
- Application Number
- CN202411165754.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-23
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-08-23
AI Technical Summary
The existing Saccharomyces cerevisiae breeding technology cannot effectively improve the yeast protein content, and the operation is cumbersome, and the adaptive evolution has led to a decrease in the protein content and poor stability, making it difficult to improve the global protein synthesis ability.
The cell morphology of Saccharomyces cerevisiae is remodeled by overexpressing the cytoskeleton and cell cycle-related genes (Gic1, Acf2, Aip1, Cln1, Cln2), integrating these genes into the Saccharomyces genome, and regulating cell morphology to improve protein synthesis capabilities.
By regulating the morphology of Saccharomyces cerevisiae, the protein content has been increased from 46.16g/100g to 51.04g/100g, achieving efficient synthesis and production efficiency of yeast protein.
Smart Images

Figure CN118909816A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a method for regulating the morphology of brewer's yeast to increase the protein content of yeast, and belongs to the technical field of microbial genetic engineering. Background Art
[0002] Existing protein production strategies cannot meet people's demand for protein. Therefore, finding more sustainable, more accessible and healthier protein sources has become the focus of current food research.
[0003] Microbial protein, namely single cell protein (SCP), has become a promising protein source. It can be obtained through fermentation and culture of industrial and agricultural waste. Compared with traditional proteins, microbial protein has a wide range of raw materials, high production efficiency and short cycle. Among them, yeast cells have been widely used in the production of organic acids, bioenergy, biomaterials, biomedicine and natural products due to their clear genetic background, complete molecular operating system and strong tolerance to environmental stress. Yeast protein is an ideal new type of alternative protein. At present, the selection and breeding of brewer's yeast to improve protein content is relatively mature, but the operation is cumbersome. Adaptive evolution to improve protein content is limited to increasing strain biomass while protein content has a certain decrease, and mutagenesis breeding has a long operation time and poor stability. Therefore, how to rationally design brewer's yeast to improve global protein synthesis capacity has begun to receive attention.
[0004] As an important part of microbial fermentation regulation, bacterial fermentation morphology regulation plays an important role in improving the production level of microorganisms in industrial fermentation and has received extensive attention. For large-volume intracellular products (such as polylactic acid and polyhydroxybutyric acid), small cell volume will affect the accumulation of products, ultimately leading to a decrease in production efficiency. The volume of microbial cells is mainly affected by their own morphology. Therefore, reshaping microbial cell morphology is an effective strategy to increase cell volume. However, some literature shows (Mapping pathways and phenotypes by systematic gene overexpression. Mol Cell 21 (3): 319-30) that overexpression of some genes affects the growth of bacterial cells and makes it difficult to achieve effective accumulation of products. Therefore, screening genes that increase protein content by regulating cell morphology is of great significance for global protein synthesis. Summary of the invention
[0005] Technical issues:
[0006] The purpose of the present invention is to overcome the shortcomings of existing breeding technology and provide a rational design method that can achieve efficient synthesis of single-cell protein of Saccharomyces cerevisiae.
[0007] Technical solution:
[0008] The present invention provides a method for regulating the morphology of Saccharomyces cerevisiae to increase the protein content of yeast, that is, reshaping the cell morphology by overexpressing cytoskeleton and cell cycle-related genes to improve the global protein synthesis capacity in Saccharomyces cerevisiae. The invention is of great significance for promoting the global synthesis of Saccharomyces cerevisiae protein and the application of alternative proteins.
[0009] The invention provides a method for regulating the morphology of saccharomyces cerevisiae and increasing the protein content of the yeast, which comprises integrating one or more genes of Gic1, Acf2, Aip1, Cln1 and Cln2 into the genome of saccharomyces cerevisiae.
[0010] In one embodiment, the method is to integrate the Gic1 gene into the genomic HO site.
[0011] In one embodiment, the method comprises the steps of:
[0012] (1) Connecting the Gic1, Acf2, Aip1, Cln1 or Cln2 gene to the plasmid pUMRI-A-△HO to obtain the recombinant plasmids pUMRI-△HO-GIC1, pUMRI-△HO-ACF2, pUMRI-△HO-AIP1, pUMRI-△HO-CLN1 and pUMRI-△HO-CLN2, respectively;
[0013] (2) Linearizing the recombinant plasmid from step (1) and integrating it into the chromosome of Saccharomyces cerevisiae by homologous recombination.
[0014] In one embodiment, the Saccharomyces cerevisiae includes but is not limited to BY4741.
[0015] The present invention also provides a recombinant Saccharomyces cerevisiae, wherein one or more genes of Gic1, Acf2, Aip1, Cln1 and Cln2 derived from Saccharomyces cerevisiae BY4741 are integrated into the genome of the recombinant Saccharomyces cerevisiae.
[0016] In one embodiment, the nucleotide sequence of the Gic1 gene is shown as SEQ ID NO.1; the nucleotide sequence of the gene Acf2 is shown as SEQ ID NO.2; the nucleotide sequence of the gene Aip1 is shown as SEQ ID NO.3; the nucleotide sequence of the gene Cln1 is shown as SEQ ID NO.4; and the nucleotide sequence of the gene Cln2 is shown as SEQ ID NO.5.
[0017] In one embodiment, the Saccharomyces cerevisiae includes but is not limited to BY4741.
[0018] The invention also provides application of the recombinant cerevisiae yeast in protein production.
[0019] In one embodiment, the use is to ferment the recombinant Saccharomyces cerevisiae in a culture medium for a period of time.
[0020] In one embodiment, the culture medium contains: tryptone (20 g / L), yeast extract (10 g / L), and galactose (20 g / L).
[0021] In one embodiment, the fermentation is carried out at 28-32°C, especially at 30°C.
[0022] In one embodiment, the fermentation is for at least 48 hours.
[0023] In one embodiment, the recombinant Saccharomyces cerevisiae is first activated in a culture medium containing tryptone, yeast extract, and glucose, and then fermented.
[0024] In one embodiment, the engineered yeast is based on the wild-type yeast BY4741 as a starting strain.
[0025] Beneficial effects:
[0026] The present invention uses wild-type BY4741 as the starting strain, screens and regulates cytoskeleton and cell cycle-related genes, reshapes cell morphology, and determines its effect on the protein content of Saccharomyces cerevisiae through fermentation verification, and determines that overexpression of Gic1 can enhance the synthesis of global proteins in Saccharomyces cerevisiae. Compared with the original strain, the protein content of the engineered bacteria increased from 46.16g / 100g to 51.04g / 100g.
[0027] The present invention regulates the cytoskeleton and cell cycle-related genes to reshape the cell morphology and achieve efficient synthesis of Saccharomyces cerevisiae protein. The method can provide a reference for the large-scale production of yeast protein. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] Figure 1 This is the morphology of yeast cells under a microscope.
[0029] Figure 2 The morphology of yeast cells under a scanning electron microscope.
[0030] Figure 3 Protein levels in recombinant Saccharomyces cerevisiae cells with different genes integrated. DETAILED DESCRIPTION
[0031] The culture medium involved in the following examples is:
[0032] YPD liquid culture medium: 20 g / L glucose, 20 g / L tryptone, 10 g / L yeast extract, sterilized by high pressure steam at 115°C for 30 min; when preparing solid plates, add 15 g / L agar powder on this basis.
[0033] YPG liquid culture medium: 20 g / L galactose, 20 g / L tryptone, 10 g / L yeast extract, sterilized by high pressure steam at 115°C for 30 min; when preparing solid plates, add 15 g / L agar powder on this basis.
[0034] 20mg / mL G418 sulfate mother solution: 0.4g G418 sulfate powder is dissolved in 20mL sterile water, filtered and sterilized using a sterilized 0.22μm water syringe filter in a clean bench, dispensed into brown centrifuge tubes, and stored at -20℃. When used, add 10μL of mother solution to every 1mL of culture medium, with a working concentration of 200μg / mL, for the preparation of YPD-G418 and YPG-G418 liquid culture medium.
[0035] LB liquid medium: NaCl 10g / L, tryptone 10g / L, yeast extract 5g / L, sterilized at 120℃ for 20min. When preparing solid plates, add 15g / L agar powder.
[0036] The final working concentration of ampicillin was 100 μg / mL; the final working concentration of kanamycin sulfate was 50 μg / mL; and the final working concentration of G418 was 200 μg / mL.
[0037] The biochemical materials involved in the following embodiments are as follows:
[0038] The wild-type strain of Saccharomyces cerevisiae BY4741 was preserved in our laboratory, and the competent Escherichia coli TOP10 was purchased from Novagen, USA.
[0039] The yeast integrative plasmid pUMRI-A-△HO was disclosed in the paper "De novo production of hydroxytyrosol by metabolic engineering of Saccharomyces cerevisiae".
[0040] The methods involved in the following embodiments are:
[0041] Determination of protein content: Collect bacterial cells in the fermentation broth, wash the cells and dry them to constant weight, and determine the protein quality by Kjeldahl nitrogen determination method, referring to GB 5009.5-2016 "National Food Safety Standard Determination of Protein in Food". Unless otherwise specified, the "protein content" mentioned in the examples refers to the amount of protein per unit cell (g 蛋白 / 100g 菌体细胞 ).
[0042] The information of the strains, genes, plasmids and primers involved in the following examples are shown in Tables 1 to 4.
[0043] Table 1 Cytoskeleton and cell cycle related genes and their functions
[0044]
[0045] Table 2: Primer list
[0046]
[0047] Table 3: Plasmid list
[0048]
[0049]
[0050] Table 4: List of strains
[0051]
[0052] Basic operations in molecular biology:
[0053] (1) E. coli plasmid extraction, genome extraction, PCR product purification, and gel recovery were performed according to the instructions of the corresponding kit unless otherwise specified.
[0054] (2) Amplify the DNA fragment using PCR technology, using different reaction systems and procedures according to experimental requirements. The reaction system refers to Table 4, and the reaction procedure refers to Table 5.
[0055] Table 5: PCR reaction system
[0056]
[0057] Table 6: PCR reaction program
[0058]
[0059]
[0060] The pUMRI-A-△HO involved in the following embodiments is disclosed in the following paper: Liu YJ, Liu H, Hu HT, et al. De Novo Production of Hydroxytyrosol by Metabolic Engineering of Saccharomyces cerevisiae[J]. Journal of Agricultural and Food Chemistry, 2022, 70(24): 7490-7499.
[0061] Example 1: Construction of yeast strain PUMRI-ΔHO-GIC1
[0062] The Gic1 fragment (nucleotide sequence as shown in SEQ ID NO.1) was amplified from the whole genome of wild-type yeast BY4741 by PCR, and the primers were Gic1-F (BamH1) and Gic1-R (Sal1). The Gic1 fragment was connected to the plasmid pUMRI-A-△HO to obtain the recombinant plasmid pUMRI-△HO-GIC1. The recombinant plasmid pUMRI-△HO-GIC1 was digested with SfiI, linearized and integrated into the HO site of BY4741 to obtain the yeast engineering strain PUMRI-△HO-GIC1. The primer nucleotide sequences are shown in Table 2, and the genotype of PUMRI-△HO-GIC1 is shown in Table 4. The PCR reaction system is shown in Table 5, and the PCR reaction procedure is shown in Table 6.
[0063] Example 2: Construction of yeast strain PUMRI-ΔHO-ACF2
[0064] The Acf2 fragment (nucleotide sequence as shown in SEQ ID NO.2) was amplified from the whole genome of wild-type yeast BY4741 by PCR, and the primers were Acf2-F (BamH1) and Acf2-R (Sal1). The Acf2 fragment was connected to the plasmid pUMRI-A-△HO to obtain the recombinant plasmid pUMRI-△HO-ACF2. The recombinant plasmid pUMRI-△HO-ACF2 was digested with SfiI, linearized and integrated into the HO site of BY4741 to obtain the yeast engineering strain PUMRI-△HO-ACF2. The primer nucleotide sequences are shown in Table 2, and the genotype of PUMRI-△HO-ACF2 is shown in Table 4. The PCR reaction system is shown in Table 5, and the PCR reaction procedure is shown in Table 6.
[0065] Example 3: Construction of yeast strain PUMRI-ΔHO-AIP1
[0066] The Aip1 fragment (nucleotide sequence as shown in SEQ ID NO.3) was amplified from the whole genome of wild-type yeast BY4741 by PCR, and the primers were Aip1-F (BamH1) and Aip1-R (Sal1). The Aip1 fragment was connected to the plasmid pUMRI-A-△HO to obtain the recombinant plasmid pUMRI-△HO-AIP1. The recombinant plasmid pUMRI-△HO-AIP1 was cut with SfiI, linearized and integrated into the HO site of BY4741 to obtain the yeast engineering strain PUMRI-△HO-AIP1. The primer nucleotide sequences are shown in Table 2, and the genotype of PUMRI-△HO-AIP1 is shown in Table 4. The PCR reaction system is shown in Table 5, and the PCR reaction procedure is shown in Table 6.
[0067] Example 4: Construction of yeast strain PUMRI-ΔHO-CLN1
[0068] The Cln1 fragment (nucleotide sequence as shown in SEQ ID NO.4) was amplified from the whole genome of wild-type yeast BY4741 by PCR, and the primers were Cln1-F (BamH1) and Cln1-R (Sal1). The Cln1 fragment was connected to the plasmid pUMRI-A-△HO to obtain the recombinant plasmid pUMRI-△HO-CLN1. The recombinant plasmid pUMRI-△HO-CLN1 was cut with SfiI, linearized and integrated into the HO site of BY4741 to obtain the yeast engineering strain PUMRI-△HO-CLN1. The primer nucleotide sequences are shown in Table 2, and the genotype of PUMRI-△HO-CLN1 is shown in Table 4. The PCR reaction system is shown in Table 5, and the PCR reaction procedure is shown in Table 6.
[0069] Example 5: Construction of yeast strain PUMRI-ΔHO-CLN2
[0070] The Cln2 fragment (nucleotide sequence as shown in SEQ ID NO.5) was amplified from the whole genome of wild-type yeast BY4741 by PCR, and the primers were Cln2-F (BamH1) and Cln2-R (Sal1). The Cln2 fragment was connected to the plasmid pUMRI-A-△HO to obtain the recombinant plasmid pUMRI-△HO-CLN2. The recombinant plasmid pUMRI-△HO-CLN2 was cut with SfiI, linearized and integrated into the HO site of BY4741 to obtain the yeast engineering strain PUMRI-△HO-CLN2. The primer nucleotide sequences are shown in Table 2, and the genotype of PUMRI-△HO-CLN2 is shown in Table 4. The PCR reaction system is shown in Table 5, and the PCR reaction procedure is shown in Table 6.
[0071] Example 6: Construction of yeast strain PUMRI-A-ΔHO
[0072] The plasmid pUMRI-A-△HO was transformed into the Saccharomyces cerevisiae BY4741 strain to obtain the yeast engineering strain PUMRI-A-△HO.
[0073] Example 7: Yeast cell culture
[0074] The strains constructed above were inoculated into YPD liquid medium and cultured at 30°C and 250 r·min -1 The cells were activated and then inoculated into 50 mL YPG liquid medium at a ratio of 2% (v / v) and incubated at 30°C and 250 r·min -1 Culture for 48h.
[0075] Microscopic observation of yeast cell morphology:
[0076] Sampling and collection A digital optical microscope with a built-in 3-megapixel digital camera (Ted Pella, Inc., Redding, CA, USA) and Motic images plus 2.0 image analysis software system was used to observe the microscopic morphology of bacterial cells in the shake flask. One drop of fermentation liquid was added to a clean and transparent slide and the optical microscopic morphology was observed. The maximum magnification was ×1000 when the oil objective was selected.
[0077] Morphological observation of yeast cells under scanning electron microscope:
[0078] The scanning electron microscopy morphology of yeast is mainly characterized by cold field emission scanning electron microscopy. The steps of cold field emission scanning electron microscopy imaging are briefly described as follows: first, the yeast cells are collected by centrifugation (12000rpm centrifugation for 1 minute), and the bacteria are washed three times with phosphate buffer; then the cells are fixed overnight with 2.5% glutaraldehyde; the cells are washed three times with phosphate buffer and collected, and dehydrated step by step with 30%, 50%, 70%, 90%, 95%, and anhydrous ethanol. Finally, the bacterial powder is obtained by low-temperature drying for imaging.
[0079] The results show Figure 1 and Figure 2, after 48 hours of fermentation, the cells were collected and observed under an optical microscope. Compared with the control strain BY4741, the overexpression of Aip1, Acf2, and Cln1 genes did not have a significant effect on the cell morphology. However, the overexpression of Cln2 and Gic1 genes caused significant changes in the morphology of Saccharomyces cerevisiae. Overexpression of Cln2 gene caused many elongated buds in Saccharomyces cerevisiae. It is speculated that this morphological defect may be due to the abnormally high level of Cln2-CDK, which causes the apical bud growth time to be prolonged. It is usually located at the bud tip and promotes the growth of the apical bud. These long buds may explain the increase in cell size. Overexpression of Gic1 gene caused the volume of Saccharomyces cerevisiae to increase significantly, and the cell surface appeared ruptured. It is speculated that the Gic1 gene can regulate the cytoskeleton component Septin ring, thereby regulating the polar growth and mitosis of Saccharomyces cerevisiae cells.
[0080] Example 8: Effect of morphological regulation on protein content of Saccharomyces cerevisiae
[0081] The strains constructed in Examples 1 to 6 were inoculated in YPD liquid medium and cultured at 30°C and 250 r·min -1 The cells were activated and then inoculated into 50 mL YPG liquid medium at a ratio of 2% (v / v) and incubated at 30°C and 250 r·min -1 Take 4 mL of fermentation broth and culture at 8000 r·min -1 Centrifuge for 10 minutes and discard the culture medium. Suspend the precipitate with sterile water and centrifuge again. Wash twice and centrifuge to discard the supernatant. Place in a 105℃ oven and dry to constant weight to measure the dry weight (DCW) of the bacteria. -1 The remaining fermentation liquid was collected by centrifugation for 10 min, washed twice with distilled water and then dried. The protein content (g / 100 g) was determined by the Kjeldahl method to screen out strains with excellent protein content and production capacity.
[0082] The fermentation results are as follows Figure 3 As shown, the protein content of strain PUMRI-△HO-GIC1 (51.04g / 100g) was significantly higher than that of the control strain BY4741 (protein content 46.16g / 100g). Gene Gic1, as a regulatory cytoskeleton-related gene, causes changes in the morphology of Saccharomyces cerevisiae. The increase in the volume of Saccharomyces cerevisiae will enhance the accumulation of proteins and increase the cellular protein content.
[0083] Therefore, by regulating the morphology of Saccharomyces cerevisiae, the cell morphology can be reshaped, efficient synthesis of Saccharomyces cerevisiae protein can be achieved, and the production efficiency of Saccharomyces cerevisiae protein can be greatly improved.
[0084] Although the present invention has been disclosed as above in the form of a preferred embodiment, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be based on the definition of the claims.
Claims
1. A recombinant Saccharomyces cerevisiae, characterized in that Overexpression of one or more genes selected from Gic1, Acf2, Aip1, Cln1, Cln2.
2. The recombinant Saccharomyces cerevisiae according to claim 1, characterized in that The Saccharomyces cerevisiae includes but is not limited to BY4741.
3. The recombinant Saccharomyces cerevisiae according to claim 1 or 2, characterized in that The nucleotide sequence of the Gic1 gene is shown in SEQ ID NO.1; the nucleotide sequence of the Acf2 gene is shown in SEQ ID NO.2; the nucleotide sequence of the Aip1 gene is shown in SEQ ID NO.3; the nucleotide sequence of the Cln1 gene is shown in SEQ ID NO.4; and the nucleotide sequence of the Cln2 gene is shown in SEQ ID NO.
5.
4. A method for regulating the morphology of brewer's yeast to increase the protein content of yeast, characterized in that: One or more genes of Gic1, Acf2, Aip1, Cln1 and Cln2 are integrated into the Saccharomyces cerevisiae genome.
5. The method according to claim 4, characterized in that The method is to integrate the Gic1 gene into the genomic HO site.
6. The method according to claim 4 or 5, characterized in that: The Saccharomyces cerevisiae includes but is not limited to BY4741.
7. Use of the recombinant Saccharomyces cerevisiae according to any one of claims 1 to 3 in protein production.
8. The use according to claim 7, characterized in that: The recombinant Saccharomyces cerevisiae is fermented in the culture medium for a period of time.
9. The use according to claim 8, characterized in that: The recombinant brewer's yeast is first activated in a culture medium containing tryptone, yeast extract and glucose, and then fermented.
10. The method according to any one of claims 7 to 9, characterized in that: The fermentation is carried out at 28-32° C. for at least 48 hours.
Citation Information
Patent Citations
Hybrid yeast with increased ethanol production
CN113646421A
Reducing acetic acid production by overexpressing yeast of MIG polypeptide
CN115552016A
Methods for improving secondary metabolite production of fungi
US20060263864A1
Increased ethanol production by overexpression of JID1 in yeast
US20230116556A1
